We have asked Petra Bloms-Funke from Grünenthal about this important Research programme on pain. What is IMI2? The Innovative Medicines Initiative 2 IMI2 is the largest public-private partnership for health research worldwide and has a €3 billion budget for the...
Co-chairs and Speaker of this Working Group Andreas Kopf, Audun Stubhaug, Axel Drews, Elsa Frazão Mateus, Johannes Wacker, José Romão, Marisol Garcia Penalta, Monique Steegers, Narinder Rawal, Nélia Gouveia, Nicola Bedlington, Oliver Scicluna, Paul A Cameron,...
“The effective management of pain is an increasing concern in the medical arena, and in the broader economic and political environment. The only way to tackle effectively this challenge is to join forces in an open collaborative way involving all...
Co-Chairs and Speaker of this Working Group Antonella Cardone, Antony Chuter, Britta Lambers, Brona Fullen, David Tjong, Decuman Saskia, Dolores Gauci, John M. Cachia, Julien Nizard, Michiel Reneman, Natasha Azzopardi Muscat, Peter Van Wambeke, Raul Marques...
Working Group 1: Pain as a quality indicator for health care Can we use pain as a quality indicator for health care? Presentation and statement by Rolf-Detlef Treede. Statement...
Health Care Agenda of the National Pain Forum 88th Conference of the Health Ministries of the German Federal States, 24/25. June 2015 Benchmarking/Quality-Assessment in Pain Management Activities in Health Care Policy Plenary Session 24 May: Statement and...
